Literature DB >> 15892972

A single amino acid change in the C-terminal domain of the matrix protein M1 of influenza B virus confers mouse adaptation and virulence.

Jonathan A McCullers1, Erich Hoffmann, Victor C Huber, Asia D Nickerson.   

Abstract

Serial passage of an initially avirulent influenza B virus, B/Memphis/12/97, resulted in the selection of a variant which was lethal in mice. Virulence correlated with improved growth in vivo and prolonged replication. Sequencing of the complete coding regions of the parent and mouse-adapted viruses revealed 8 amino acid differences. Sequencing and characterization of intermediate passages suggested that one change in the C-terminal domain of the M1 protein, an asparagine to a serine at position 221, was responsible for acquisition of virulence and lethality. Site-directed mutagenesis of the M segment of a different virus, B/Yamanashi/166/98, to change this amino acid residue confirmed its importance by conferring improved growth and virulence in mice. This observation suggests a role for the C domain of the M1 protein in growth and virulence in a mammalian host.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15892972      PMCID: PMC2737340          DOI: 10.1016/j.virol.2005.03.028

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  41 in total

1.  Reassortment and insertion-deletion are strategies for the evolution of influenza B viruses in nature.

Authors:  J A McCullers; G C Wang; S He; R G Webster
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Restriction of viral replication by mutation of the influenza virus matrix protein.

Authors:  Teresa Liu; Zhiping Ye
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Association of influenza virus matrix protein with ribonucleoproteins may control viral growth and morphology.

Authors:  Teresa Liu; Jacqueline Muller; Zhiping Ye
Journal:  Virology       Date:  2002-12-05       Impact factor: 3.616

Review 4.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

Review 5.  Mutations in the hemagglutinin and matrix genes of a virulent influenza virus variant, A/FM/1/47-MA, control different stages in pathogenesis.

Authors:  C A Smeenk; K E Wright; B F Burns; A J Thaker; E G Brown
Journal:  Virus Res       Date:  1996-10       Impact factor: 3.303

6.  Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1.

Authors:  B Sha; M Luo
Journal:  Nat Struct Biol       Date:  1997-03

7.  Specific changes in the M1 protein during adaptation of influenza virus to mouse.

Authors:  A C Ward
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

8.  Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domains.

Authors:  M Krystal; J F Young; P Palese; I A Wilson; J J Skehel; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

9.  Studies on the genetic determinants of influenza virus pathogenicity for mice with the use of reassortants between mouse-adapted and non-adapted variants of the same virus strain.

Authors:  I A Rudneva; N V Kaverin; N L Varich; A K Gitelman; A M Makhov; S M Klimenko; V M Zhdanov
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

10.  The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid.

Authors:  W P Burmeister; R W Ruigrok; S Cusack
Journal:  EMBO J       Date:  1992-01       Impact factor: 11.598

View more
  24 in total

1.  Transmission of influenza B viruses in the guinea pig.

Authors:  Natalie Pica; Yi-Ying Chou; Nicole M Bouvier; Peter Palese
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

Review 2.  Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.

Authors:  Andrew J Burnham; Tatiana Baranovich; Elena A Govorkova
Journal:  Antiviral Res       Date:  2013-09-04       Impact factor: 5.970

3.  Mutations in influenza virus M1 CCHH, the putative zinc finger motif, cause attenuation in mice and protect mice against lethal influenza virus infection.

Authors:  Eric Ka-Wai Hui; Donald F Smee; Min-Hui Wong; Debi P Nayak
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  A nuclear export signal in the matrix protein of Influenza A virus is required for efficient virus replication.

Authors:  Shuai Cao; Xiaoling Liu; Maorong Yu; Jing Li; Xiaojuan Jia; Yuhai Bi; Lei Sun; George F Gao; Wenjun Liu
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

5.  Palmitoylation is required for intracellular trafficking of influenza B virus NB protein and efficient influenza B virus growth in vitro.

Authors:  Andrew Demers; Zhiguang Ran; Qiji Deng; Dan Wang; Brody Edman; Wuxun Lu; Feng Li
Journal:  J Gen Virol       Date:  2014-03-26       Impact factor: 3.891

6.  In vitro and in vivo replication of influenza A H1N1 WSN33 viruses with different M1 proteins.

Authors:  Zhiguang Ran; Ying Chen; Huigang Shen; Xiaoxiao Xiang; Qinfang Liu; Bhupinder Bawa; Wenbao Qi; Laihua Zhu; Alan Young; Juergen Richt; Wenjun Ma; Feng Li
Journal:  J Gen Virol       Date:  2012-12-19       Impact factor: 3.891

Review 7.  H5N1 pathogenesis studies in mammalian models.

Authors:  Jessica A Belser; Terrence M Tumpey
Journal:  Virus Res       Date:  2013-02-28       Impact factor: 3.303

8.  Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach.

Authors:  Rong Hai; Luis Martínez-Sobrido; Kathryn A Fraser; Juan Ayllon; Adolfo García-Sastre; Peter Palese
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

9.  Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus.

Authors:  Victor C Huber; Loren H Kleimeyer; Jonathan A McCullers
Journal:  Vaccine       Date:  2008-08-15       Impact factor: 3.641

10.  Characterization of the nucleocytoplasmic shuttle of the matrix protein of influenza B virus.

Authors:  Shuai Cao; Jingwen Jiang; Jing Li; Yan Li; Limin Yang; Shanshan Wang; Jinghua Yan; George F Gao; Wenjun Liu
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.